Sector: In Vitro And In Vivo Diagnostic Substances Region: MN, United States

: | Nasdaq: TECH

Bio-Techne (formerly Techne Corp.), NASDAQ: TECH, is a global life sciences company providing innovative bioactive tools and resources for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With over 24,000 products in its portfolio, Bio-Techne generated approximately $311 million in net sales in FY 2013 and has over 1,000 employees worldwide. For more information on Bio-Techne and its brands, please visit

Investor Calendar

Oct 31, 2017 9:00 am | Q1 Earnings Call

News & Analysis